NEW YORK (GenomeWeb News) – Shares of PerkinElmer climbed just above 15 percent in afternoon trading on the New York Stock Exchange following its announcement after the close of the market yesterday of strong first-quarter results.
PerkinElmer’s shares climbed as high as 20 percent to $27.25 during the trading session before settling back to $26.18 in the afternoon.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.